IPO Research
Global Leader in Independent Analysis for Institutional Investors

Institutional IPO investors rely on our independent IPO research for unbiased and comprehensive coverage of the U.S. and international IPO markets. Our subscription service provides in-depth fundamental analysis and customizable financial models on all institutionally investable IPOs. Our clients also gain access to www.ipointelligence.com, the premier IPO knowledge base with deal calendars, market commentary, fundamental data on over 5,000 past IPOs and more. For more information, please contact us.

Independent: Balanced research, not just a Wall Street sales pitch
Fills Gap: Pre IPO Research and during the "Quiet Period" when no coverage is available
Disciplined: Consistent framework for evaluating unseasoned equities
Smart: Track record of distinguishing good IPOs from bad
Comprehensive: Coverage of all newly public companies, popular or not
Multi-Category: Covers all investment styles and industries
Institutional: Our clients manage over $2 trillion in assets
Renaissance Ratings Track Record
1-Month Returns from Midpoint (Rolling 3-yr)
Renaissance Research
Pre-IPO Coverage List
Company Country Industry
Kamada Israel Health Care
Epizyme US Health Care
RCS Capital US Financial
Bombardier Recr Canada Consumer
Portola Pharmac US Health Care
Constellium Netherlands Materials
ChannelAdvisor US Technology
Global Brass an US Materials
Ply Gem Holding US Capital Goods &
William Lyon Ho US Capital Goods &
Ambit Bioscienc US Health Care
Marketo US Technology
Renaissance Capital also provides consulting services to corporations, management teams, board members, financial sponsors, accountants and attorneys seeking our independent advice about going public, stock option valuation and IPO market activity. These services include:

  • Pre- and Post-IPO Stock Option Valuation Analytics
  • Deal Structuring
  • IPO Timing Advice
  • Expert Witness Services
To find out more about our services, please complete our Contact Form.
The Most Trusted Opinion on IPOs Subscribe to ResearchView Research Process